<?xml version="1.0" encoding="UTF-8"?>
<p>Of the 102 patients, 41 (median age, 61 [range, 24–93] years) died, with an overall mortality rate of 40.1%. The median duration of illness before death was 18.5 (range, 2–53) days. Nine patients (21.9%) died within seven days after symptom onset. Of 41 deceased patients, 80.5% had influenza A virus and 19.5% had influenza B virus infection. Of the 38 deceased patients who received oseltamivir treatment, 76.3% of patients received oseltamivir more than 48 h after onset of the illness (
 <xref rid="jcm-09-01073-t004" ref-type="table">Table 4</xref>). Among the 41 deceased patients, pneumonia developed in 39 (95.1%) patients, acute kidney injury in 33 (80.5%), ARDS in 27 (65.9%), gastrointestinal bleeding in 21 (51.2%), and bacteremia in 6 (35.3%) patients (
 <xref rid="jcm-09-01073-t004" ref-type="table">Table 4</xref>).
</p>
